155 related articles for article (PubMed ID: 15817123)
1. Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer.
Li J; Kleeff J; Abiatari I; Kayed H; Giese NA; Felix K; Giese T; Büchler MW; Friess H
Mol Cancer; 2005 Apr; 4(1):14. PubMed ID: 15817123
[TBL] [Abstract][Full Text] [Related]
2. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
3. HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma.
Lai JP; Chien J; Strome SE; Staub J; Montoya DP; Greene EL; Smith DI; Roberts LR; Shridhar V
Oncogene; 2004 Feb; 23(7):1439-47. PubMed ID: 14973553
[TBL] [Abstract][Full Text] [Related]
4. Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.
Lai J; Chien J; Staub J; Avula R; Greene EL; Matthews TA; Smith DI; Kaufmann SH; Roberts LR; Shridhar V
J Biol Chem; 2003 Jun; 278(25):23107-17. PubMed ID: 12686563
[TBL] [Abstract][Full Text] [Related]
5. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.
Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X
Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394
[TBL] [Abstract][Full Text] [Related]
6. HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells.
Khurana A; Liu P; Mellone P; Lorenzon L; Vincenzi B; Datta K; Yang B; Linhardt RJ; Lingle W; Chien J; Baldi A; Shridhar V
Cancer Res; 2011 Mar; 71(6):2152-61. PubMed ID: 21266348
[TBL] [Abstract][Full Text] [Related]
7. Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer.
Narita K; Chien J; Mullany SA; Staub J; Qian X; Lingle WL; Shridhar V
J Biol Chem; 2007 May; 282(19):14413-20. PubMed ID: 17363371
[TBL] [Abstract][Full Text] [Related]
8. Hsulf-1 regulates growth and invasion of pancreatic cancer cells.
Abiatari I; Kleeff J; Li J; Felix K; Büchler MW; Friess H
J Clin Pathol; 2006 Oct; 59(10):1052-8. PubMed ID: 16603650
[TBL] [Abstract][Full Text] [Related]
9. Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model.
Xu G; Ji W; Su Y; Xu Y; Yan Y; Shen S; Li X; Sun B; Qian H; Chen L; Fu X; Wu M; Su C
Oncotarget; 2014 Jul; 5(13):5029-39. PubMed ID: 24970807
[TBL] [Abstract][Full Text] [Related]
10. Glypican-1 antisense transfection modulates TGF-beta-dependent signaling in Colo-357 pancreatic cancer cells.
Li J; Kleeff J; Kayed H; Felix K; Penzel R; Büchler MW; Korc M; Friess H
Biochem Biophys Res Commun; 2004 Aug; 320(4):1148-55. PubMed ID: 15249209
[TBL] [Abstract][Full Text] [Related]
11. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
[TBL] [Abstract][Full Text] [Related]
12. HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo.
Dai Y; Yang Y; MacLeod V; Yue X; Rapraeger AC; Shriver Z; Venkataraman G; Sasisekharan R; Sanderson RD
J Biol Chem; 2005 Dec; 280(48):40066-73. PubMed ID: 16192265
[TBL] [Abstract][Full Text] [Related]
13. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.
Kleeff J; Ishiwata T; Kumbasar A; Friess H; Büchler MW; Lander AD; Korc M
J Clin Invest; 1998 Nov; 102(9):1662-73. PubMed ID: 9802880
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions.
Kornmann M; Ishiwata T; Beger HG; Korc M
Oncogene; 1997 Sep; 15(12):1417-24. PubMed ID: 9333017
[TBL] [Abstract][Full Text] [Related]
15. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract][Full Text] [Related]
16. Human sulfatase 1 exerts anti-tumor activity by inhibiting the AKT/ CDK4 signaling pathway in melanoma.
Lou X; Sun B; Song J; Wang Y; Jiang J; Xu Y; Ren Z; Su C
Oncotarget; 2016 Dec; 7(51):84486-84495. PubMed ID: 27806323
[TBL] [Abstract][Full Text] [Related]
17. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
[TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
Zhu Z; Kleeff J; Kayed H; Wang L; Korc M; Büchler MW; Friess H
Mol Carcinog; 2002 Nov; 35(3):138-47. PubMed ID: 12410565
[TBL] [Abstract][Full Text] [Related]
19. The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.
Liu P; Gou M; Yi T; Qi X; Xie C; Zhou S; Deng H; Wei Y; Zhao X
Int J Oncol; 2012 Oct; 41(4):1504-12. PubMed ID: 22825572
[TBL] [Abstract][Full Text] [Related]
20. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
